No evidence for enhanced adipocyte differentiation in patients with postmenopausal osteoporosis.

被引：0
|
作者：
Justesen, J
Stenderup, K
Steiniche, T
Eriksen, EF
Kassem, M
机构：
[1] Aarhus Kommune Hosp, Dept Endocrinol & Metab, Aarhus, Denmark
[2] Aarhus Univ, Aarhus Kommune Hosp, Inst Pathol, DK-8000 Aarhus, Denmark
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU177
引用
收藏
页码：S476 / S476
页数：1
相关论文
共 50 条
  • [41] Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis.
    Shea, B
    Guyatt, G
    Cranney, A
    Krolicki, N
    Welch, V
    Griffith, I
    Ortiz, Z
    Peterson, J
    Adachi, JD
    Tugwell, P
    Wells, G
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S290 - S290
  • [42] Growth hormone increases bone mineral content in postmenopausal osteoporosis.
    Landin-Wilhelmsen, KLL
    Nilsson, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S222 - S222
  • [43] Time since last fracture: An important variable for the inquiry of quality of life in patients with postmenopausal osteoporosis.
    Begerow, B
    Pfeifer, M
    Scholz, M
    Hass, K
    Lazarescu, AD
    Schlotthauer, T
    Pollaehne, W
    Minne, HW
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M706 - M706
  • [44] Factors Associated with Sub-optimal Adherence to Bisphosphonate Therapy among Patients with Postmenopausal Osteoporosis.
    DerSarkissian, Maral
    O'Malley, Cynthia
    Ferreira, Irene
    Silverman, Stuart
    Gold, Deborah
    Wagman, Rachel
    Grauer, Andreas
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S196 - S196
  • [45] Daily and intermittent oral ibandronate: An evaluation of bone histomorphometry in postmenopausal osteoporosis.
    Recker, RR
    Meunier, PJ
    Chesnut, CH
    Hughes, C
    Bonvoisin, B
    Weinstein, RS
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S448 - S449
  • [46] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis.
    Adachi, JD
    Reginster, J
    Qu, Y
    Siddhanti, S
    Keech, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S379 - S379
  • [47] Comparison of risedronate, calcitonin and active vitamin D treatments in postmenopausal osteoporosis.
    Ota, N
    Shibata, Y
    Ito, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S308 - S308
  • [48] Adherence with drug therapy and risk of fracture among women with postmenopausal osteoporosis.
    Weycker, D
    Macarios, D
    Oster, G
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S383 - S383
  • [49] Validation of the Gail model for breast cancer risk in postmenopausal women with osteoporosis.
    Goldstein, S.
    Yeo, A.
    Qu, Y.
    Wong, M.
    Mitchell, B.
    Mershon, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S175 - S176
  • [50] The role of bone ultrasonography in the therapeutic follow-up of postmenopausal osteoporosis.
    Grosso, I
    Casalis, S
    Isaia, G
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S348 - S348
12345